A 45-year-old man is admitted to the emergency center after developing severe chest pain while raking leaves. On admission he has mid chest dullness and a normal EKG. The physician schedules the patient for cardiac catheterization with coronary angiography and possible PCI (percutaneous coronary intervention). The nurse prepares the patient for the procedure by explaining that, in this case, it is used to

A. should notify the physician of the irregular rhythm: Sinus arrhythmia is a normal physiologic variation in heart rate, particularly in younger adults, and is generally benign. Notification of the physician is not required unless the patient develops symptoms or other abnormalities are present.

B. knows that the irregularity is caused by electrical instability of the ventricles: Sinus arrhythmia originates in the SA node and reflects normal autonomic modulation of heart rate with respiration, not ventricular electrical instability. Ventricular instability would present with different arrhythmias such as PVCs or ventricular tachycardia.

C. assesses that inspiration and expiration is associated with the irregularity: Sinus arrhythmia is characterized by a slight increase in heart rate during inspiration and a decrease during expiration due to changes in vagal tone. Recognizing this pattern confirms that the rhythm is normal and does not require intervention.

D. prepares for electrical cardioversion: Electrical cardioversion is reserved for unstable or symptomatic arrhythmias, such as atrial fibrillation or ventricular tachycardia. Sinus arrhythmia is benign and does not require cardioversion or any urgent intervention.

A. anti-inflammatory: While aspirin has anti-inflammatory properties, the primary reason it is prescribed for a client with a history of myocardial infarction is not to reduce inflammation but to prevent thrombotic events. Anti-inflammatory effects are secondary in this context.

B. analgesic: Aspirin can relieve mild pain, such as headaches or musculoskeletal discomfort. However, in post-MI management, pain relief is not the therapeutic goal; the focus is on preventing further cardiac events.

C. antiplatelet aggregate: Aspirin inhibits platelet aggregation by irreversibly blocking cyclooxygenase-1 (COX-1) and thromboxane A2 formation. This reduces the risk of clot formation in coronary arteries, preventing recurrent myocardial infarction or other thromboembolic events, which is why it is prescribed at this dosage for post-MI patients.

D. antipyretic: Aspirin can lower fever by affecting the hypothalamic thermoregulatory center, but antipyretic effects are not relevant in the management of a patient with a history of myocardial infarction.